These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38721894)

  • 21. Natural history and outcome of neuroendocrine carcinoma of the cervix.
    Margolis B; Tergas AI; Chen L; Hou JY; Burke WM; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2016 May; 141(2):247-254. PubMed ID: 26873865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-kit overexpression in neuroendocrine small cell carcinoma of the uterine cervix.
    Ohwada M; Wada T; Saga Y; Tsunoda S; Jobo T; Kuramoto H; Konno R; Suzuki M
    Eur J Gynaecol Oncol; 2006; 27(1):53-5. PubMed ID: 16550970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer.
    Backman M; La Fleur L; Kurppa P; Djureinovic D; Elfving H; Brunnström H; Mattsson JSM; Lindberg A; Pontén V; Eltahir M; Mangsbo S; Gulyas M; Isaksson J; Jirström K; Kärre K; Leandersson K; Mezheyeuski A; Pontén F; Strell C; Lindskog C; Botling J; Micke P
    J Pathol; 2021 Nov; 255(3):243-256. PubMed ID: 34339045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of clinicopathological characteristics and comprehensive treatment models on the prognosis of small cell carcinoma of the cervix: A systematic review and meta-analysis.
    Zhang Q; Xiong Y; Ye J; Zhang L; Li L
    PLoS One; 2018; 13(4):e0192784. PubMed ID: 29641578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study.
    Megyesfalvi Z; Barany N; Lantos A; Valko Z; Pipek O; Lang C; Schwendenwein A; Oberndorfer F; Paku S; Ferencz B; Dezso K; Fillinger J; Lohinai Z; Moldvay J; Galffy G; Szeitz B; Rezeli M; Rivard C; Hirsch FR; Brcic L; Popper H; Kern I; Kovacevic M; Skarda J; Mittak M; Marko-Varga G; Bogos K; Renyi-Vamos F; Hoda MA; Klikovits T; Hoetzenecker K; Schelch K; Laszlo V; Dome B
    J Pathol; 2022 Aug; 257(5):674-686. PubMed ID: 35489038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
    Choi S; Kim H; Heo YJ; Kang SY; Ahn S; Lee J; Kim KM
    J Pathol; 2023 Aug; 260(4):443-454. PubMed ID: 37341658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes.
    De Cecco L; Serafini MS; Facco C; Granata R; Orlandi E; Fallai C; Licitra L; Marchesi E; Perrone F; Pilotti S; Quattrone P; Piazza C; Sessa F; Turri-Zanoni M; Battaglia P; Castelnuovo P; Antognoni P; Canevari S; Bossi P
    Oral Oncol; 2019 Mar; 90():94-101. PubMed ID: 30846184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic characterization of small cell carcinomas of the uterine cervix.
    Schultheis AM; de Bruijn I; Selenica P; Macedo GS; da Silva EM; Piscuoglio S; Jungbluth AA; Park KJ; Klimstra DS; Wardelmann E; Hartmann W; Gerharz CD; von Petersdorff M; Buettner R; Reis-Filho JS; Weigelt B
    Mol Oncol; 2022 Feb; 16(4):833-845. PubMed ID: 33830625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small cell neuroendocrine carcinomas of the lung do not harbor high-risk human papillomavirus.
    Hartley CP; Steinmetz HB; Memoli VA; Tafe LJ
    Hum Pathol; 2015 Apr; 46(4):577-82. PubMed ID: 25661244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer.
    Frumovitz M; Burzawa JK; Byers LA; Lyons YA; Ramalingam P; Coleman RL; Brown J
    Gynecol Oncol; 2016 Jun; 141(3):588-591. PubMed ID: 27079212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of organoid culture from HPV18-positive small cell carcinoma of the uterine cervix for precision medicine.
    Kusakabe M; Taguchi A; Tanikawa M; Hoshi D; Tsuchimochi S; Qian X; Toyohara Y; Kawata A; Wagatsuma R; Yamaguchi K; Yamamoto Y; Ikemura M; Sone K; Mori-Uchino M; Matsunaga H; Tsuruga T; Nagamatsu T; Kukimoto I; Wada-Hiraike O; Kawazu M; Ushiku T; Takeyama H; Oda K; Kawana K; Hippo Y; Osuga Y
    Cancer Med; 2023 Apr; 12(7):8476-8489. PubMed ID: 36691316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequencing-based transcriptome analysis reveals diversification of immune response- and angiogenesis-related expression patterns of early-stage cervical carcinoma as compared with high-grade CIN.
    Kurmyshkina OV; Dobrynin PV; Kovchur PI; Volkova TO
    Front Immunol; 2023; 14():1215607. PubMed ID: 37731500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of outcome in small cell carcinoma of the cervix--a case series.
    Straughn JM; Richter HE; Conner MG; Meleth S; Barnes MN
    Gynecol Oncol; 2001 Nov; 83(2):216-20. PubMed ID: 11606074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological analysis of nine cases of small cell carcinoma of the uterine cervix].
    Deng GH; Zhang X; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):199-202. PubMed ID: 20450588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level.
    Liu Y; Qi L; Ye B; Wang A; Lu J; Qu L; Luo P; Wang L; Jiang A
    Cancer Biol Ther; 2024 Dec; 25(1):2345977. PubMed ID: 38659199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis.
    Cavalcanti MS; Schultheis AM; Ho C; Wang L; DeLair DF; Weigelt B; Gardner G; Lichtman SM; Hameed M; Park KJ
    Int J Gynecol Pathol; 2017 Jan; 36(1):76-89. PubMed ID: 27532149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
    Manzano RG; Catalan-Latorre A; Brugarolas A
    BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center.
    Sharabi A; Kim SS; Kato S; Sanders PD; Patel SP; Sanghvi P; Weihe E; Kurzrock R
    Oncologist; 2017 Jun; 22(6):631-637. PubMed ID: 28550027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
    Wright AA; Howitt BE; Myers AP; Dahlberg SE; Palescandolo E; Van Hummelen P; MacConaill LE; Shoni M; Wagle N; Jones RT; Quick CM; Laury A; Katz IT; Hahn WC; Matulonis UA; Hirsch MS
    Cancer; 2013 Nov; 119(21):3776-83. PubMed ID: 24037752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
    Kawamura M; Koide Y; Murai T; Ishihara S; Takase Y; Murao T; Okazaki D; Yamaguchi T; Uchiyama K; Itoh Y; Kodaira T; Shibamoto Y; Mizuno M; Kikkawa F; Naganawa S
    BMC Cancer; 2021 Sep; 21(1):1046. PubMed ID: 34556082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.